Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
Saved in:
| Title: | Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen. |
|---|---|
| Authors: | Yang MH; Department of Oncology, Division of Medical Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Chen TH; Department of Oncology, Division of Medical Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Wang HM; Department of Internal Medicine, Division of Hematology-Oncology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan., Hsieh JC; Department of Internal Medicine, Division of Hematology-Oncology, New Taipei City Municipal TuCheng Hospital, New Taipei City, Taiwan., Huang HC; Department of Oncology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Hsieh MC; Department of Hematology and Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan., Wu SY; Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan., Hua CH; Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan., Lien MY; Department of Internal Medicine, Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan., Chang YF; Department of Hematology, MacKay Memorial Hospital, Taipei, Taiwan., Wang HC; Department of Internal Medicine, Division of Hematology and Oncology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan., Chien CY; Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, Taiwan., Huang TL; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan., Lu HJ; Department of Internal Medicine, Division of Hematology and Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan., Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan., Wang CC; Department of Otolaryngology-Head and Neck Surgery, Taichung Veterans General Hospital, Taichung City, Taiwan., Liu YC; Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan., Chen JP; Department of Oncology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan., Lu WC; Department of Oncology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan., Yiu CY; Department of Otolaryngology, Chi Mei Medical Center, Liouying, No. 201, Taikang Village, Liouying District, Tainan City, 736402, Taiwan., Lin CL; Department of Internal Medicine, Division of Hematology-Oncology, Chi Mei Medical Center, Liouying, Tainan, Taiwan., Lou PJ; Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Chu PY; Department of Otolaryngology, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217, Taiwan, ROC. pychu@vghtpe.gov.tw. |
| Source: | BMC cancer [BMC Cancer] 2024 Oct 05; Vol. 24 (1), pp. 1227. Date of Electronic Publication: 2024 Oct 05. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-024-12425-0 |
